Advertisment Nexovas Cilnidipine
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:1015

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (470 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   References
   Article Tables

 Article Access Statistics
    Viewed419    
    Printed18    
    Emailed0    
    PDF Downloaded36    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
LETTER TO EDITOR
Year : 2019  |  Volume : 29  |  Issue : 2  |  Page : 148
 

Urinary sediment profile in proliferative and nonproliferative glomerulonephritis by bright-field and phase-contrast microscopy


1 Department of Histopathology, Apollo Hospitals, Jubilee Hills, Hyderabad, India
2 Department of Clinical Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, India

Date of Web Publication20-Mar-2019

Correspondence Address:
S Gowrishankar
Department of Histopathology, 6th Floor, Health Street Building, Apollo Hospitals, Jubilee Hills, Hyderabad - 500 096
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijn.IJN_37_18

Rights and Permissions



How to cite this article:
Joshi P, Vanajakshi S, Gowrishankar S. Urinary sediment profile in proliferative and nonproliferative glomerulonephritis by bright-field and phase-contrast microscopy. Indian J Nephrol 2019;29:148

How to cite this URL:
Joshi P, Vanajakshi S, Gowrishankar S. Urinary sediment profile in proliferative and nonproliferative glomerulonephritis by bright-field and phase-contrast microscopy. Indian J Nephrol [serial online] 2019 [cited 2019 Jul 16];29:148. Available from: http://www.indianjnephrol.org/text.asp?2019/29/2/148/249863




Sir,

We report herein a study demonstrating the value of urine sediment profile in distinguishing proliferative glomerulonephritis (PGN) from nonproliferative glomerulonephritis (NPGN). This distinction is of clinical importance as it helps the nephrologist recognize PGNs which usually need urgent attention and a biopsy on priority.

The study included 129 biopsy proven cases, 57 of PGN and 72 of NPGN. The urine sample in each case was collected prior to the biopsy, processed according to the meticulous protocol, and all cells and casts in the sediment were semiquantitatively scored according to the method proposed by Fogazzi.[1] The sediment was examined by bright-field, polarizing, and phase contrast microscopy in all cases. The latter is of particular importance in recognizing dysmorphic RBCs, which were reported as a percentage of the total RBCs.

The results of the study are summarized in [Table 1].
Table 1: P value of urine particles in proliferative glomerulonephritis and nonproliferative glomerulonephritis: Quantitative analysis

Click here to view


RBCs, dysmorphic RBCs, WBCs, RBC casts, and renal tubular epithelial casts were significantly higher in PGN. A discriminant analysis with the dependent variables being PGN and NPGN and the independent variables being RBC, WBC, and RBC casts yielded a sensitivity of 91.23% and specificity of 58.33% in our study, whilst that done by Fogazzi et al.[2] yielded a sensitivity and specificity of 80.8% and 79.2%, respectively.

Dysmorphic RBCs have long been considered a hallmark of glomerular hematuria. The percentage of dysmorphic RBCs used as a cutoff has varied from as low as 20%[3] to as high as 90%.[4],[5] In this study, a cutoff of >40% dysmorphic RBCs had a sensitivity of 91.2% and a specificity of 79.17% in distinguishing PGN from NPGN.

In summary, urine sediment analysis when accurately performed is of value in predicting the type of glomerulopathy. As dysmorphic RBCs are seen in nonproliferative GN also, a cutoff of 40% can be used as a screening procedure to recognize proliferative GN which need urgent clinical attention and biopsies.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Fogazzi GB. Collection, Preparation and Examination of the Samples, and Report of Urinary Findings, in the Urinary Sediment an Integrated View. 3rd ed. Elsevier; 2009. p. 22-6.  Back to cited text no. 1
    
2.
Fogazzi GB, Saglimbeni L, Banfi G, Cantú M, Moroni G, Garigali G, et al. Urinary sediment features in proliferative and non-proliferative glomerular diseases. J Nephrol 2005;18:703-10.  Back to cited text no. 2
    
3.
Mohammad KS, Bdesha AS, Snell ME, Witherow RO, Coleman DV. Phase contrast microscopic examination of urinary erythrocytes to localise source of bleeding: An overlooked technique? J Clin Pathol 1993;46:642-5.  Back to cited text no. 3
    
4.
De Santo NG, Nuzzi F, Capodicasa G, Lama G, Caputo G, Rosati P, et al. Phase contrast microscopy of the urine sediment for the diagnosis of glomerular and nonglomerular bleeding-data in children and adults with normal creatinine clearance. Nephron 1987;45:35-9.  Back to cited text no. 4
    
5.
Catalá López JL, Fábregas Brouard M. Acanthocyturia is more efficient in to differentiate glomerular from non-glomerular hematuria then dysmorphic erythrocytes. Arch Esp Urol 2002;55:164-6.  Back to cited text no. 5
    



 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07